Bone Marrow TransplantationTransplantation, HomologousBone MarrowTransplantation ConditioningGraft vs Host DiseaseBone Marrow CellsWhole-Body IrradiationTransplantation, AutologousHematopoietic Stem Cell TransplantationBusulfanTransplantation ChimeraAnemia, AplasticGraft SurvivalLeukemiaCyclophosphamideBone and BonesSyndromeTissue DonorsHistocompatibility TestingHematologic NeoplasmsConditioning, ClassicalHistocompatibilityMyeloablative AgonistsLiver TransplantationBone Marrow PurgingTreatment OutcomeVidarabineCombined Modality TherapyRecurrenceImmunosuppressive AgentsConditioning (Psychology)Hematopoietic Stem CellsTransplantation, IsogeneicRemission InductionHepatic Veno-Occlusive DiseaseStem Cell TransplantationMelphalanLeukemia, Myeloid, AcuteMyelodysplastic SyndromesHematopoiesisTime FactorsBone Marrow DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft RejectionSurvival AnalysisMice, Inbred C57BLPrecursor Cell Lymphoblastic Leukemia-LymphomaAntilymphocyte SerumKidney TransplantationLymphocyte DepletionRadiation ChimeraLymphoma, Non-HodgkinAcute DiseaseAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesGraft vs Tumor EffectLeukemia, MyeloidConditioning, EyelidSevere Combined ImmunodeficiencyDisease-Free SurvivalImmunosuppressionHLA AntigensBone Marrow ExaminationCord Blood Stem Cell TransplantationHematologic DiseasesCyclosporineChimerismT-LymphocytesCytarabineSurvival RatePeripheral Blood Stem Cell TransplantationCarmustineChimeraBone RemodelingTransplantation ImmunologyFollow-Up StudiesEtoposideBone Marrow NeoplasmsMultiple MyelomaGraft vs Host ReactionLymphocyte TransfusionHemibody IrradiationLeukocyte TransfusionHeart TransplantationNuclear FamilyGraft vs Leukemia EffectInfectionColony-Forming Units AssayHodgkin DiseaseGranulocyte Colony-Stimulating FactorLung TransplantationActuarial AnalysisLymphomaPrognosisSalvage TherapyBone DensityAnemia, Refractory, with Excess of BlastsMice, Inbred BALB CPancytopeniaHematopoietic Stem Cell Mobilization